Status: closed

Saver Study

Statins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot

 

Why are we doing this study

This is a small study designed to test if a larger, more long term study would be feasible.
The goal is to see whether, rosuvastatin, a drug that treats high cholesterol, can reduce the **post- thrombotic syndrome (PTS) complications in patients with Deep Vein Thrombosis(DVT) and/or Pulmonary Embolism (PE) even in patients that don’t necessarily have high cholesterol.

 

Who is eligible

Patient diagnosed with a blood clot, either in the deep veins of the leg or in the lungs, in the last 30 days.

 

What is the study treatment plan

Participants will be randomized( assigned by chance) to one of two groups:

  • Patients who will take 20 mg of rosuvastatin (Treatment group)
  • Patients who will not be given rosuvastatin and proceed with usual care (Control group)

 

What is involved if I participate in the study

You will have up to four visits over a six month period:

  • Screening visit
  • Randomization visit
  • Telephone follow-up ( 90 days)
  • Final visit (180 days)

** you can look up what is PTS on this site

 

SAVER Study Coordinator

David Morrison
TEL:       (514) 340-8222  ext. 22178